Single-agent docetacel (D) versus docetaxel alternating with single-agent gemcitabine (G) as treatments of patients (pts) with advanced breast cancer (ABC): Final analysis of a randomized trial

Abstract only

Saved in:
Bibliographic Details
Published inJournal of clinical oncology Vol. 26; no. 15_suppl; p. 1035
Main Authors Joensuu, H., Sailas, L., Alanko, T., Sunela, K., Huuhtanen, R., Utriainen, M., Kokko, R., Bono, P., Hahka-Kemppinen, M., Kellokumpu-Lehtinen, P.
Format Journal Article
LanguageEnglish
Published 20.05.2008
Online AccessGet full text

Cover

More Information
Summary:Abstract only
ISSN:0732-183X
1527-7755
DOI:10.1200/jco.2008.26.15_suppl.1035